Allogene Therapeutics, Inc. · NASDAQ:ALLO

Citadel Advisors LLC's stake in Allogene Therapeutics, Inc. fell to 2.80% (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

Citadel Advisors LLC's stake in Allogene Therapeutics, Inc. fell to 2.80%, 6,855,120 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
2.80%
Shares
6,855,120
Intent
Passive
What changed
Fell below 5%
Filed together
7 holders

The filing in full

HolderStakeShares
Citadel Advisors LLC2.40%5,795,242
Citadel Advisors Holdings LP2.40%5,795,242
Citadel GP LLC2.40%5,795,242
Citadel Securities LLC0.30%614,069
Citadel Securities Group LP0.40%1,059,878
Citadel Securities GP LLC0.40%1,059,878
Kenneth Griffin2.80%6,855,120

Source

View original at SEC

Related